Management Team
MDxHealth was established by a management team with extensive biotechnology industry experience.
Jan Groen, Ph.D.
Chief Executive Officer
Dr. Jan Groen joined MDxHealth in 2010 and has more than 25 years of experience in the clinical diagnostics industry, with a particular focus on emerging technologies, product development and commercialization.
Dr. Groen was previously the president of Agendia, Inc. and COO of Agendia B.V., responsible for their United States and European diagnostic operations, respectively. Prior to this, he served as VP of Research & Development at Focus Diagnostics, Inc., a subsidiary of Quest Diagnostics, in California. Dr. Groen has held numerous management and scientific positions at ViroClinics B.V., the Erasmus Medical Center, and Akzo-Nobel. Dr. Jan Groen is a supervisory board member of IBL International B.V.
Dr. Groen holds a Ph.D. degree in Medical Microbiology from the Erasmus University Rotterdam, a BSc in Clinical Laboratory Studies and has published more than 125 papers in international scientific journals in the field of clinical diagnostics.
James Clark Ph.D.
Vice President of Research & Development
James Clark has in the past been extensively involved in the development and commercialization of biomarkers and companion diagnostics within both GSK-Biologicals and Response Genetics. At GSK-Biologicals he was Technology group head for cancer vaccines and was involved in the development of a companion diagnostic. At Response Genetics, as Chief Operating Officer, he led the team that successfully applied for CLIA laboratory and test certification as well as CE marking of products in Europe.
James Clark holds a Ph.D. in Biochemistry from Glasgow University in Scotland and a BSC in Microbiology from Heriot–Watt University in Edinburgh.
Joseph Sollee
Vice President of Corporate Development and Legal Affairs
Mr. Sollee has provided legal counsel to MDxHealth since its inception in 2003, and in April 2008 joined our management team.
Prior to joining the Company, Mr. Sollee served as Special Counsel with the law firm of Kennedy Covington (now K&LGates), where he led the Life Sciences Practice Group. Mr. Sollee has more than 10 years of experience in the biotech industry, and has held senior legal and management positions at Triangle Pharmaceuticals and TherapyEdge. In addition, he has practiced as a corporate attorney in the Washington D.C. legal firm Swidler & Berlin and as an investment banker at Smith Barney in New York.
Mr. Sollee received a Juris Doctorate in Law and a Masters degree in International Law from Duke University, a BA degree from Harvard University, and has been awarded New York, Washington D.C. and North Carolina legal bar certifications.
Philip Devine
Chief Financial Officer
Mr. Devine (represented by DECOFI sprl) joined MDxHealth at the inception of the company as a co-founder. Prior to joining MDxHealth, Mr. Devine served as CFO of Tibotec-Virco, where he managed its sale to Johnson & Johnson.
Previously, he was a manager at the management consulting firm McKinsey & Company and an auditor at Deloitte & Touche, where he conducted numerous mergers and acquisitions, led initial public offerings, and served both small and Fortune 500 companies.
Mr. Devine earned his CPA license in Massachusetts, an MBA degree from INSEAD, an MSA degree from Bentley College and a BA degree from Dartmouth College.
Wim van Criekinge Prof., Ph.D.
Vice President of Science & Technology
Prof. Van Criekinge (represented by Bioformatrix bvba) joined MDxHealth in August 2005. He graduated in 1994 as a Chemical Engineer from the University of Ghent, Belgium, where he also earned his Ph.D. degree in Molecular Biology in 1998.
Today he is part-time Professor at the same university, where he is head of the laboratory for computational genomics and bioinformatics (Biobix) in the department of molecular biotechnology. In 1997, he was co-founder and director of Devgen, a successful public biotechnology company.
Miriam Reyes
Senior Director Laboratory Operations
Miriam has over 12 years of experience in molecular diagnostics, specifically focused on R&D and lab operations. As Senior Director Laboratory Operations, Mrs. Reyes is responsible for MDxHealth CLIA lab operations in the U.S.
Previously, Miriam Reyes was Director Lab Operations at Agendia and she built the CLIA lab for the Agendia’s MammaPrint breast cancer test. Prior to Agendia, she held various laboratory positions at US Labs, Combimatrix Molecular Diagnostics and IBIS Biosciences.
Mrs. Reyes is a certified laboratory specialist in molecular biology; she holds a bachelor degree in science as well as a MBA degree in healthcare from the University of California in Irvine.
Christopher Thibodeau
Vice President of Commercial Operations
Chris Thibodeau brings over 15 years of sales, marketing and commercial leadership experience in the diagnostics arena. As Vice President Commercial Operations, he is responsible for developing and executing MDxHealth’s key strategic sales & marketing and business development initiatives.
Prior to joining MDxHealth, Mr. Thibodeau served as Senior Director of Marketing at Agendia Inc., Vice President of Sales and Marketing for Numira Biosciences, National Director of Sales US LABS (an industry leader in cancer diagnostic and genomic testing services); and sales and marketing management roles at Ventana Medical.
Mr. Thibodeau holds a BSc degree from the East Stroudsburg University in Pennsylvania and studied at the Faculté des Lettres in Nancy, France.
Joseph Bigley, M.Sc.
Vice President of Clinical Affairs
Mr. Bigley joined MDxHealth at inception from Tibotec-Virco where he was director oncology clinical research since January 2001. Prior to Tibotec-Virco, Mr. Bigley was director clinical operations and associate clinical director of oncology at Triangle Pharmaceuticals.
Mr. Bigley held various clinical R&D positions within Burroughs Wellcome and Glaxo Wellcome, including head of the experimental oncology section and senior manager of the HIV program development. Mr. Bigley worked for Hoffmann-La Roche in the areas of preclinical cancer and viral drug discovery and clinical research.
Mr. Bigley is a member of the American Association for Clinical Research (AACR) and the American Society of Clinical Oncology (ASCO). Mr. Bigley holds a MSc. degree from Fairleigh Dickinson University in Rutherford, New Jersey, USA.